Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Livermore

Showing results (41-50 of 269) with videos related to

Pageof 27
Sort By:
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas sppMariana Castanheira, Ronald N Jones, David M Livermore
FEMS Microbiology Reviews|February 10, 2011
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistanceNeil Woodford, Jane F Turton, David M Livermore
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Properties and potential of ertapenemDavid M Livermore, Armine M Sefton, Geoffrey M Scott
International Journal of Antimicrobial Agents|January 10, 2013
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocciRussell Hope, Aiysha Chaudhry, Rachael Adkin, et al.
International Journal of Antimicrobial Agents|January 4, 2024
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistanceShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
International Journal of Antimicrobial Agents|March 9, 2023
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coliDavid M Livermore, Shazad Mushtaq, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Detection of CTX-M-15 extended-spectrum beta-lactamase in the United KingdomShazad Mushtaq, Neil Woodford, Nicola Potz, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2007
Activity of faropenem against cephalosporin-resistant EnterobacteriaceaeShazad Mushtaq, Russell Hope, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|January 19, 2007
In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter sppNeil Woodford, Robert L R Hill, David M Livermore
Antimicrobial Agents and Chemotherapy|April 6, 2016
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumanniiDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Pageof 27

Showing results (41-50 of 269) with videos related to

Sort By:
Pageof 27
Diagnostic Microbiology and Infectious Disease|March 3, 2009
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas sppMariana Castanheira, Ronald N Jones, David M Livermore
FEMS Microbiology Reviews|February 10, 2011
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistanceNeil Woodford, Jane F Turton, David M Livermore
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Properties and potential of ertapenemDavid M Livermore, Armine M Sefton, Geoffrey M Scott
International Journal of Antimicrobial Agents|January 10, 2013
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocciRussell Hope, Aiysha Chaudhry, Rachael Adkin, et al.
International Journal of Antimicrobial Agents|January 4, 2024
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistanceShazad Mushtaq, Anna Vickers, Neil Woodford, et al.
International Journal of Antimicrobial Agents|March 9, 2023
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coliDavid M Livermore, Shazad Mushtaq, Anna Vickers, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2003
Detection of CTX-M-15 extended-spectrum beta-lactamase in the United KingdomShazad Mushtaq, Neil Woodford, Nicola Potz, et al.
The Journal of Antimicrobial Chemotherapy|March 14, 2007
Activity of faropenem against cephalosporin-resistant EnterobacteriaceaeShazad Mushtaq, Russell Hope, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|January 19, 2007
In vitro activity of tigecycline against carbapenem-susceptible and -resistant isolates of Klebsiella spp. and Enterobacter sppNeil Woodford, Robert L R Hill, David M Livermore
Antimicrobial Agents and Chemotherapy|April 6, 2016
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumanniiDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Pageof 27